|
| | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- Basic information |
| Product Name: | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- | | Synonyms: | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]-;1-[N-[[2-(1-Amino-2-methylbuyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucine]bacitracin F;N2-[N-[[2-(1-Amino-2-methylbutyl)-4,5-dihydrothiazol-4-yl]carbonyl]-L-Leu-D-Glu-L-Ile-]cyclo(L-Lys-D-Orn-L-Ile-D-Phe-L-His-D-Asp-L-Asn-);Solu-tracin 50;L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-α-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-, (10→4)-lactam;Bacitracin A (Technical Grade) | | CAS: | 22601-59-8 | | MF: | C66H103N17O16S | | MW: | 1422.71 | | EINECS: | 245-115-9 | | Product Categories: | | | Mol File: | 22601-59-8.mol | ![Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- Structure](CAS/20180808/GIF/22601-59-8.gif) |
| | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- Chemical Properties |
| Melting point | >190°C (dec.) | | storage temp. | 2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | pKa | 4.01±0.10(Predicted) | | Boiling point | 1755.5±65.0 °C(Predicted) | | density | 1.43±0.1 g/cm3(Predicted) | | form | Solid | | color | White to Pale Yellow | | Stability: | Hygroscopic |
| | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- Usage And Synthesis |
| Uses | Bacitracin A is a peptide antibiotic. | | Definition | ChEBI: Bacitracin A is a homodetic cyclic peptide consisting of (4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid attached head-to-tail to L-leucyl,D-glutamyl, L-lysyl, D-ornityl, L-isoleucyl, D-phenylalanyl, L-histidyl. D-aspartyl and L-asparaginyl residues coupled in sequence and cyclised by condensation of the side-chain amino group of the L-lysyl residue with the C-terminal carboxylic acid group. It is the major component of bacitracin. It has a role as an antibacterial agent and an antimicrobial agent. It is a homodetic cyclic peptide and a polypeptide. |
| | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- Preparation Products And Raw materials |
|
